Skip to content
healthcare.dev

INVEGA

NDC 50458-551, paliperidone, tablet, extended release, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-551
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021999
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-551 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALIPERIDONE6 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
50458-551-015045805510130 TABLET, EXTENDED RELEASE in 1 BOTTLE (50458-551-01)
50458-551-98504580551987 TABLET, EXTENDED RELEASE in 1 BOTTLE (50458-551-98)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7b8e5b26-b9e4-4704-921b-3c3c0d159916
  • NADAC price for package 50458055101

    GET /v1/drugs/nadac/50458055101

Use it

Look up 50458-551 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-551 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-551. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.